Cell Culture Market Growth Strategies and Future Trends 2023: Research by Top Countries Data and Industry Segments

Cell Culture Market Growth Strategies and Future Trends 2023: Research by Top Countries Data and Industry Segments
Key players in the cell culture market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), and Sartorius AG (Germany), Corning Incorporated (US).
Global cell culture market in terms of revenue was estimated to be worth $27.9 billion in 2023 and is poised to reach $51.3 billion by 2028

The cell culture industry is expected to experience strong growth in the near future as advances in biotechnology, stem cell research, and tissue engineering continue to progress. The growth of the cell culture market is driven by increased demand for cell culture-based products and services across various industries. Additionally, the development of new technologies and the emergence of innovative product offerings have further strengthened the market’s growth potential.

Cell Culture Market in terms of revenue was estimated to be worth $27.9 billion in 2023 and is poised to reach $51.3 billion by 2028, growing at a CAGR of 12.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the increasing government support and funding for cell-based research, adoption of single-use technologies, emerging cell culture technologies for cell-based vaccines and incidence of infectious diseases. On the other hand, the expensive cell biology research is restraining the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559

Browse in-depth TOC on “Cell Culture Market” 

692 – Tables 

42 – Figures 

556 – Pages

The equipment segment accounted for the second largest share, by product in the the cell culture market in 2022.

Based on equipment, the cell culture market is segmented into supporting equipment, bioreactors, and storage equipment. Cell culture involves the extensive use of laboratory equipment such as bioreactors, storage equipment, and cell culture-supporting equipment. The growing awareness about the benefits of cell culture-based vaccines (coupled with the growing regulatory approval for these products), increasing production of mAbs, and the introduction of technologically advanced products for high-demand applications (such as cell & gene therapy and regenerative medicine) are the key factors driving the growth of the cell culture equipment market.

The monoclonal antibody production segment accounted for the largest share of the biopharmaceutical production segment in the cell culture market in 2022.

Based on biopharmaceutical production, the cell culture market is categorized into monoclonal antibody production, vaccine production, and other therapeutic protein production. Monoclonal antibodies are multifunctional components of the immune system that fight infections. Most antibodies generated as a natural response are polyclonal, which means they are produced by several B lymphocytes. Monoclonal antibodies, on the contrary, are produced in laboratories and can bind to single specific targets in the body, such as antigens on the surface of certain cancer cells.

The North America region catered the largest share of the cell culture market in 2022.

The growing regulatory approvals for and awareness of cell culture-based vaccines, rising investments in biopharmaceutical R&D coupled with various initiatives from the leading companies, and conferences and symposia that create awareness of the latest cell culture trends are the key factors driving the growth of the cell culture market in North America. Biopharmaceutical companies in North America focus on R&D activities to develop and commercialize novel drugs and therapies. Additionally, various initiatives from leading companies have accelerated growth in North America.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=559

Cell Culture Market Dynamics:

Drivers:

  1. Government support and funding for cell-based research
  2. Emerging cell culture technologies for cell-based vaccines
  3. Growing popularity of monoclonal antibodies
  4. Adoption of single-use technologies
  5. Growing focus on product development
  6. Growth in cell and gene therapies and stem cell research
  7. Incidence of infectious diseases

Restraints:

  1. High cost of cell biology research
  2. Limitations in producing high-density cell cultures

Opportunities:

  1. Demand for 3D over 2D cell cultures
  2. Growth hotspots in emerging economies

Challenges:

  1. Disposal of plastic consumables

Key Market Players:

Key players in the cell culture market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), and Sartorius AG (Germany), Corning Incorporated (US).

Recent Developments

  • In February 2022, Thermo Fisher Scientific announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the US.
  • In October 2022, Cytiva acquired Cevec Pharmaceuticals GmbH, which is expected to strengthen Cytiva’s leading position in biomanufacturing solutions.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=559

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html